Saitama, Japan

Masami Takei



Average Co-Inventor Count = 9.2

ph-index = 1

Forward Citations = 27(Granted Patents)


Location History:

  • Sayama, JP (2004)
  • Saitama, JP (2004 - 2005)

Company Filing History:


Years Active: 2004-2005

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Masami Takei in IgA Nephropathy Research

Introduction

Masami Takei is a notable inventor based in Saitama, Japan, recognized for his contributions to the field of medical research, particularly in relation to IgA nephropathy. He holds three patents that focus on novel DNA and proteins associated with this condition, which affects kidney function.

Latest Patents

Takei's latest patents include groundbreaking work on IgA nephropathy-related DNA. This novel DNA exhibits fluctuating expression levels in leukocytes of IgA nephropathy patients compared to those of healthy individuals. His patents also encompass a process for isolating this DNA, a novel protein encoded by it, and an antibody that recognizes this protein. Furthermore, he has developed methods for detecting both the protein and the DNA, as well as diagnostic and treatment methods for IgA nephropathy. Another significant patent involves IgA nephropathy-related genes, which were identified using a differential display method. This invention also includes processes for isolating and detecting the DNA, along with methods for diagnosing and treating the disease.

Career Highlights

Throughout his career, Masami Takei has worked with esteemed institutions such as Nihon University and Kyowa Hakko Kogyo Co., Ltd. His research has significantly advanced the understanding of IgA nephropathy and its underlying genetic factors.

Collaborations

Takei has collaborated with notable colleagues, including Tetsuyoshi Ishiwata and Mikiko Sakurada, who have contributed to his research endeavors.

Conclusion

Masami Takei's innovative work in the field of IgA nephropathy has led to important advancements in diagnosis and treatment, showcasing his dedication to improving patient outcomes. His contributions continue to influence the medical research community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…